Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor (Q28167338)
Jump to navigation
Jump to search
scientific article (publication date: 18 February 2004)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor |
scientific article (publication date: 18 February 2004) |
Statements
Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor (English)
0 references
18 February 2004
0 references
43
0 references
4
0 references
526-31
0 references